Vantex CVC in gloved hand over blue sterile barrier
Vantex CVC in gloved hand over blue sterile barrier

ASA recommends antimicrobial CVCs to reduce CLABSI risk

The 2020 ASA Practice Guidelines for CVC Insertion recommend the use of silver/platinum/carbon-impregnated catheters over uncoated catheters for most effective CLABSI risk reduction.1 The Vantex CVC meets ASA guidelines using time-release silver ions extruded throughout the body of the catheter, internally and externally, to decrease risk of catheter-related blood stream infection (CRBSI).

Download ASA guidelines

HOW IT PERFORMS

Vantex helps reduce CLABSI and more—better than other CVCs

CLABSIs occur in 3 to 7% of CVC placements and cost up to $45,000 per occurrence.2,3 Studies demonstrate the Vantex® CVC’s efficacy at reducing and preventing CLABSIs.4,5,6

graphic stat 75% more CLABSI reduction than uncoated CVC

Outperforms uncoated CVCs

Vantex prevented more bacterial colonization and CLABSIs than polyurethane CVCs.5

graphic stat 48.5% more CLABSI reduction than CHG silver sulfadiazine catheters

Outperforms chlorhexidine-silver sulfadiazine catheters

Pairing both with education, Vantex outperformed silver CHG coated catheters.4 Adding a sterile barrier kit and CHG prep, Vantex reduced CLABSI to 1.6/1000 line days.

graphic: 3-8% of people have a sulfa allergy; Vantex eliminates sulfa allergy risk

Eliminates sulfa allergy risk

Vantex’ extruded silver/carbon/platinum composition eliminates anaphylactic shock risk associated with sulfa in chlorhexidine- silver sulfadiazine catheters.

features and benefits

Vantex CVCs improve patient safety and streamline clinician workflow

CVC with the year 2000 to represent more than 20 years of Vantex efficacy as a proven technology

Proven technology

Vantex has more than 20 years of proven clinical efficacy.7

Vantex CVC with needleless valves for ease of use

Ease of use

Pre-attached needleless valves save clinicians time.

Vantex CVC with soft tip reduces risk of injury

Less risk of injury

A soft tip reduces the risk of vessel perforation.8

Vantex CVC with clear lumens, color coded hubs and lumen labels assist correct use

Intuitive design

Clear extension lumens enable better fluid path visualization. Color coded hubs and lumen labels make identification easy.

Visit our catalog for product details   

Experience the Vantex CVC: Request a bundle sample

Please complete and submit the form and a Medline specialist will arrange your insertion bundle sample including a Vantex CVC.

CVC insertion bundle with sterile barrier and components
* Indicates required field

Explore how bundles help improve CLABSI prevention

Set the CVC line up for success from insertion. Our intuitively designed insertion bundle provides clinicians with every supply they need at the bedside. The sequenced tray guides the procedure step-by-step supporting consistent best practice, aseptic technique, efficiency and patient safety.

VASCULAR ACCESS HEALTH SOLUTION

Make CLABSI prevention second nature

Improve outcomes and sustain a culture of safety throughout your organization with our comprehensive solution including vascular access best practices, education and training, and a system of products tailored to your needs.

References:

  1. Practice Guidelines for Central Venous Access 2020: An Updated Report by the American Society of Anesthesiologists Task Force on Central Venous Access. Anesthesiology January 2020, Vol. 132, 8–43. https://pubs.asahq.org/anesthesiology/article/132/1/8/108838/Practice-Guidelines-for-Central-Venous-Access. Accessed March 1, 2022
  2. Darouiche RO. Device- Associated Infections: A Macroproblem that Starts with Microadherence. Clinical Infectious Disease. 2001;33:1567-1572.
  3. Zimlichman E, Henderson D, Tamir O et al. Health care- associated infections: A meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039-2046.
  4. Ranucci M, et al. Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Crit Care Med 2003;31(1):52-59.
  5. Corral L, Ibanez-Nolla J, Leon M et al. A prospective, randomized study in critically ill patients using the Oligon™ Vantex® catheter. J of Hosp Infection. 2003;55:212-219.
  6. Fraenkel D, Rickard C, Thomas P et al. A prospective, randomized trial of rifampicin-minocycline coated and silver-platinum-carbon-impregnated central venous catheters. Crit Care Med. Article in Press. 2006; 34(3): 668-675.
  7. Data on file.
  8. Gravenstien N, Blackshear RH. In Vitro Evaluation of Relative Performance of Central Venous Catheters: Comparison of Materials, Selected Models, Number of Lumens, and Angles of Incidence to Simulate Membrane. J Clin Monit. 7:1-6:1991.
  9. Giles, A., Foushee, J., Lantz, E., & Gumina, G. (2019). Sulfonamide Allergies. Pharmacy (Basel, Switzerland), 7(3), 132. https://doi.org/10.3390/pharmacy7030132